Press Releases

02/28/2020

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy

Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, rare cells

12/10/2019

New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Northwestern University researchers use gold standard  liquid-biopsy technology to deepen understanding of metastatic breast cancer

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells

05/30/2018

Circulating Tumor Cells to Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 30, 2018 -- Menarini Silicon Biosystems announced today that a new study has found that using circulating tumor cells (CTCs), a form of liquid biopsy, holds promise as a key tool for developing a staging system that can have a significant impact in the treatment of metastatic breast cancer (MBC).

continue →

Topics: Circulating tumor cells, metastatic breast cancer